Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Spyre Therapeutics priced 4,117,648 common shares at $85 for expected gross proceeds of ~$350M, with a 30-day option for up to ~$52.5M more. Closing is expected on or about Oct. 7, 2026, subject to customary conditions.Material DetailsContext by AI AnalystThis is a follow-on raise to fund an expand…
Spyre Therapeutics priced an underwritten public offering of 4,117,648 common shares at USD 85.00 each, expecting about USD 350 million gross proceeds. Underwriters have a 30-day option for up to about USD 52.5 million more. Closing targeted for Oct. 7, 2026, subject to customary conditions.